Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 9 studies | 44% ± 13% | |
astrocyte | 9 studies | 39% ± 16% | |
mast cell | 7 studies | 22% ± 3% | |
epithelial cell | 6 studies | 25% ± 13% | |
type II pneumocyte | 6 studies | 43% ± 10% | |
microglial cell | 5 studies | 23% ± 5% | |
cardiac muscle cell | 5 studies | 38% ± 11% | |
endothelial cell | 4 studies | 22% ± 7% | |
monocyte | 4 studies | 24% ± 3% | |
macrophage | 4 studies | 26% ± 5% | |
retinal pigment epithelial cell | 3 studies | 35% ± 23% | |
GABAergic neuron | 3 studies | 40% ± 6% | |
glutamatergic neuron | 3 studies | 47% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 4% | |
dendritic cell | 3 studies | 16% ± 1% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 23% ± 4% | |
alveolar macrophage | 3 studies | 23% ± 7% | |
club cell | 3 studies | 18% ± 2% | |
type I pneumocyte | 3 studies | 18% ± 2% | |
interneuron | 3 studies | 33% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 4153.76 | 1809 / 1809 | 100% | 45.50 | 470 / 472 |
prostate | 100% | 2020.40 | 245 / 245 | 99% | 28.08 | 499 / 502 |
pancreas | 100% | 2395.63 | 327 / 328 | 99% | 30.03 | 177 / 178 |
intestine | 99% | 2972.99 | 957 / 966 | 100% | 41.80 | 527 / 527 |
lung | 100% | 3694.45 | 576 / 578 | 99% | 32.04 | 1148 / 1155 |
stomach | 100% | 2670.17 | 358 / 359 | 99% | 41.42 | 284 / 286 |
ovary | 100% | 3532.86 | 180 / 180 | 99% | 30.20 | 424 / 430 |
breast | 100% | 2652.40 | 458 / 459 | 99% | 46.25 | 1104 / 1118 |
esophagus | 99% | 1806.44 | 1429 / 1445 | 99% | 37.65 | 182 / 183 |
uterus | 100% | 1450.48 | 170 / 170 | 98% | 25.10 | 451 / 459 |
adrenal gland | 100% | 2548.57 | 258 / 258 | 97% | 26.48 | 224 / 230 |
thymus | 100% | 3136.83 | 653 / 653 | 97% | 18.69 | 586 / 605 |
bladder | 100% | 1545.05 | 21 / 21 | 96% | 25.63 | 485 / 504 |
brain | 93% | 1395.22 | 2460 / 2642 | 100% | 24.50 | 703 / 705 |
kidney | 100% | 2157.70 | 89 / 89 | 91% | 13.66 | 822 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.30 | 29 / 29 |
muscle | 100% | 3589.26 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2127.15 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 29.15 | 45 / 45 |
adipose | 100% | 2908.07 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1538.52 | 1327 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 26.21 | 79 / 80 |
heart | 96% | 2954.81 | 828 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 2746.12 | 865 / 929 | 0% | 0 | 0 / 0 |
liver | 15% | 107.05 | 33 / 226 | 50% | 6.38 | 201 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0160020 | Biological process | positive regulation of ferroptosis |
GO_0016020 | Cellular component | membrane |
Gene name | TMEM164 |
Protein name | Transmembrane protein 164 Transmembrane protein 164 (cDNA: FLJ22679 fis, clone HSI10687) |
Synonyms | hCG_20304 RP13-360B22.2 |
Description | FUNCTION: Positive regulator of ferroptosis. Selectively mediates ATG5-dependent autophagosome formation during ferroptosis, rather than during starvation, and regulates the degradation of ferritin, GPX4 and lipid droplets to increase iron accumulation and lipid peroxidation, thereby promoting ferroptotic cell death. . |
Accessions | ENST00000372073.5 [Q5U3C3-1] ENST00000372072.7 [Q5U3C3-2] ENST00000288381.4 Q5U3C3 ENST00000372068.7 [Q5U3C3-1] A1PI58 |